Literature DB >> 20574553

The uses and limitations of whole-body magnetic resonance imaging.

Gerwin Schmidt1, Dietmar Dinter, Maximilian F Reiser, Stefan O Schoenberg.   

Abstract

BACKGROUND: Whole-body magnetic resonance imaging (WB-MRI) is a modern imaging method, free of ionizing radiation, which provides high-resolution display of individual organ systems and of the anatomy of the entire body.
METHODS: Selective literature review
RESULTS: Multi-channel WB-MRI scanners enable both the high-resolution imaging of the entire body and focused studies of individual organs, through the use of various sequence techniques and contrast modes. The initial application of combined cardiovascular and oncological imaging protocols for the screening of asymptomatic persons has already revealed many cases of cardiovascular disease and of tumors with serious clinical implications. The diagnostic accuracy of M staging with WB-MRI lies in the range of 93% to 97%. WB-MRI provides good contrast of the bone marrow, and has thus been used for the diagnosis of malignant bone marrow disease as well: in particular, it is especially sensitive for multiple myeloma and plays an important role in prognostication and therapeutic decision-making in this disorder. To date, WB-MRI has not been shown to be superior to other diagnostic techniques with respect to hard endpoints, such as prolongation of survival. It also carries the risk of false positive findings.
CONCLUSION: Despite these encouraging results, undirected screening by WB-MRI without an appropriate indication, as is currently being practiced in many institutions, is decidedly inadvisable in view of its predicted diagnostic yield below 2% and the lack of evidence for its cost-effectiveness.

Entities:  

Mesh:

Year:  2010        PMID: 20574553      PMCID: PMC2890065          DOI: 10.3238/arztebl.2010.0383

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  20 in total

Review 1.  [Whole body MRI--diagnostic strategy of the future?].

Authors:  M Goyen; H-P Schlemmer
Journal:  Radiologe       Date:  2007-10       Impact factor: 0.635

2.  [Cost considerations for whole-body MRI and PET/CT as part of oncologic staging].

Authors:  C Plathow; M Walz; M P Lichy; P Aschoff; C Pfannenberg; H Bock; S M Eschmann; C D Claussen; H P Schlemmer
Journal:  Radiologe       Date:  2008-04       Impact factor: 0.635

3.  High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study.

Authors:  Gerwin P Schmidt; Bernd Wintersperger; Anno Graser; Andrea Baur-Melnyk; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Invest Radiol       Date:  2007-06       Impact factor: 6.016

4.  The value of diffusion-weighted imaging in combination with T2-weighted imaging for rectal cancer detection.

Authors:  Sheng-Xiang Rao; Meng-Su Zeng; Cai-Zhong Chen; Ren-Chen Li; Shu-Jie Zhang; Jian-Ming Xu; Ying-Yong Hou
Journal:  Eur J Radiol       Date:  2007-05-10       Impact factor: 3.528

5.  Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy.

Authors:  Dietmar Jörg Dinter; Wolfgang K Neff; Johanna Klaus; Christoph Böhm; Jan Hastka; Christel Weiss; Stefan O Schoenberg; Georgia Metzgeroth
Journal:  Ann Hematol       Date:  2008-10-22       Impact factor: 3.673

6.  Systemic cardiovascular complications in patients with long-standing diabetes mellitus: comprehensive assessment with whole-body magnetic resonance imaging/magnetic resonance angiography.

Authors:  Sabine Weckbach; Hannes M Findeisen; Stefan O Schoenberg; Harald Kramer; Renee Stark; Dirk A Clevert; Maximilian F Reiser; Klaus G Parhofer
Journal:  Invest Radiol       Date:  2009-04       Impact factor: 6.016

7.  Whole-body MRI versus whole-body MDCT for staging of multiple myeloma.

Authors:  Andrea Baur-Melnyk; Sonja Buhmann; Christoph Becker; Stefan Oswald Schoenberg; Nicola Lang; Reiner Bartl; Maximilian Ferdinand Reiser
Journal:  AJR Am J Roentgenol       Date:  2008-04       Impact factor: 3.959

8.  [Preventive whole-body screening encompassing modern imaging using magnetic resonance tomography].

Authors:  Dietrich Baumgart; Thomas Egelhof
Journal:  Herz       Date:  2007-08       Impact factor: 1.443

9.  Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.

Authors:  Gerwin P Schmidt; Andrea Baur-Melnyk; Alexander Haug; Volker Heinemann; Ingo Bauerfeind; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Eur J Radiol       Date:  2007-12-20       Impact factor: 3.528

10.  Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.

Authors:  G P Schmidt; A Baur-Melnyk; A Haug; S Utzschneider; C R Becker; R Tiling; M F Reiser; K A Hermann
Journal:  Eur Radiol       Date:  2009-02-04       Impact factor: 5.315

View more
  5 in total

1.  Advantages in vascular tumors.

Authors:  Jendrik Hardes; Georg Gosheger
Journal:  Dtsch Arztebl Int       Date:  2010-10-22       Impact factor: 5.594

2.  [Magnetic resonance imaging in rheumatology].

Authors:  H Kellner; W Kellner
Journal:  Z Rheumatol       Date:  2011-08       Impact factor: 1.372

Review 3.  Whole-body magnetic resonance imaging of pediatric cancer predisposition syndromes: special considerations, challenges and perspective.

Authors:  Sandra Saade-Lemus; Andrew J Degnan; Michael R Acord; Abhay S Srinivasan; Janet R Reid; Sabah E Servaes; Lisa J States; Sudha A Anupindi
Journal:  Pediatr Radiol       Date:  2019-10-16

4.  Whole Body MRI in the Detection of Lymph Node Metastases in Patients with Testicular Germ Cell Cancer.

Authors:  Vassiliki Pasoglou; Sandy Van Nieuwenhove; Julien Van Damme; Nicolas Michoux; Aline Van Maanen; Laurence Annet; Jean-Pascal Machiels; Bertrand Tombal; Frederic E Lecouvet
Journal:  Life (Basel)       Date:  2022-01-29

5.  Whole-body magnetic resonance imaging of Li-Fraumeni syndrome patients: observations from a two rounds screening of Brazilian patients.

Authors:  Daniele Paixão; Marcos Duarte Guimarães; Kelvin César de Andrade; Amanda França Nóbrega; Rubens Chojniak; Maria Isabel Achatz
Journal:  Cancer Imaging       Date:  2018-08-14       Impact factor: 3.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.